Literature DB >> 23549937

Clinical staging in psychiatry: a cross-cutting model of diagnosis with heuristic and practical value.

Jan Scott, Marion Leboyer, Ian Hickie, Michael Berk, Flavio Kapczinski, Ellen Frank, David Kupfer, Patrick McGorry.   

Abstract

Staging models are used routinely in general medicine for potentially serious or chronic physical disorders such as diabetes, arthritis and cancers, describing the links between biomarkers, clinical phenotypes and disease extension, and promoting a personalised or stratified medicine approach to treatment planning. Clinical staging involves a detailed description of where an individual exists on a continuum of disorder progression from stage 0 (an at-risk or latency stage) through to stage IV (late or end-stage disease). The approach is popular owing to its clinical utility and is increasingly being applied in psychiatry. The concept offers an informed approach to research and the active promotion of indicated prevention and early intervention strategies. We suggest that for young persons with emerging bipolar disorder, such transdiagnostic staging models could provide a framework that better reflects the developmental psychopathology and matches the complex longitudinal inter-relationships between subsyndromal and syndromal mood, psychotic and other disorders.

Entities:  

Mesh:

Year:  2013        PMID: 23549937     DOI: 10.1192/bjp.bp.112.110858

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  69 in total

Review 1.  The Kraepelinian dichotomy viewed by neuroimaging.

Authors:  Marc-Antoine d'Albis; Josselin Houenou
Journal:  Schizophr Bull       Date:  2014-12-22       Impact factor: 9.306

2.  Functional deterioration from the premorbid period to 2 years after the first episode of psychosis in early-onset psychosis.

Authors:  Ángel Del Rey-Mejías; David Fraguas; Covadonga M Díaz-Caneja; Laura Pina-Camacho; Josefina Castro-Fornieles; Inmaculada Baeza; Ana Espliego; Jessica Merchán-Naranjo; Ana González-Pinto; Elena de la Serna; Beatriz Payá; Montserrat Graell; Celso Arango; Mara Parellada
Journal:  Eur Child Adolesc Psychiatry       Date:  2015-03-01       Impact factor: 4.785

3.  The next stage for diagnosis: validity through utility.

Authors:  Patrick D McGorry
Journal:  World Psychiatry       Date:  2013-10       Impact factor: 49.548

Review 4.  Toward a comprehensive clinical staging model for bipolar disorder: integrating the evidence.

Authors:  Anne Duffy
Journal:  Can J Psychiatry       Date:  2014-12       Impact factor: 4.356

5.  From Perception to Thought: A Phenomenological Approach to Hallucinatory Experience.

Authors:  Andrea Raballo
Journal:  Schizophr Bull       Date:  2016-11-21       Impact factor: 9.306

6.  Concepts and misconceptions regarding clinical staging models.

Authors:  Jai Shah; Jan Scott
Journal:  J Psychiatry Neurosci       Date:  2016-10       Impact factor: 6.186

7.  Transdiagnostic psychiatry: a systematic review.

Authors:  Paolo Fusar-Poli; Marco Solmi; Natascia Brondino; Cathy Davies; Chungil Chae; Pierluigi Politi; Stefan Borgwardt; Stephen M Lawrie; Josef Parnas; Philip McGuire
Journal:  World Psychiatry       Date:  2019-06       Impact factor: 49.548

Review 8.  Recent advances in sleep-wake cycle and biological rhythms in bipolar disorder.

Authors:  Rébecca Robillard; Sharon L Naismith; Ian B Hickie
Journal:  Curr Psychiatry Rep       Date:  2013-10       Impact factor: 5.285

9.  Early psychosis research at Orygen, The National Centre of Excellence in Youth Mental Health.

Authors:  S M Cotton; K M Filia; A Ratheesh; K Pennell; S Goldstone; P D McGorry
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2016-01       Impact factor: 4.328

10.  McLean OnTrack: a transdiagnostic program for early intervention in first-episode psychosis.

Authors:  Ann K Shinn; Kirsten W Bolton; Rakesh Karmacharya; Kathryn E Lewandowski; Cagri Yuksel; Justin T Baker; Virginie-Anne Chouinard; Samira M Pingali; Hilary Bye; Katherine Cederbaum; Dost Öngür
Journal:  Early Interv Psychiatry       Date:  2015-11-29       Impact factor: 2.732

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.